Monopar Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MNPR and other ETFs, options, and stocks.About MNPR
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages.
MNPR Key Statistics
Stock Snapshot
The current Monopar Therapeutics(MNPR) stock price is $75.03, with a market capitalization of 503.33M. The stock trades at a price-to-earnings (P/E) ratio of -21.82.
As of 2026-01-24, Monopar Therapeutics(MNPR) stock has fluctuated between $72.50 and $76.13. The current price stands at $75.03, placing the stock +3.5% above today's low and -1.5% off the high.
The Monopar Therapeutics(MNPR)'s current trading volume is 348.62K, compared to an average daily volume of 318.68K.
In the last year, Monopar Therapeutics(MNPR) shares hit a 52-week high of $105.00 and a 52-week low of $26.06.
In the last year, Monopar Therapeutics(MNPR) shares hit a 52-week high of $105.00 and a 52-week low of $26.06.
Analyst ratings
100%
of 14 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.